Home | Cancers | Lung Cancer

Lung Cancer

Lung cancer is rarely detected by current x-ray procedures

Each year, nearly 3000 Norwegians develop lung cancer. Current x-ray- examinations capture only 20 percent of cases. With modern ultralow-dose CT, the ...

Targeted drugs get first test in early stage lung cancer

The National Cancer Institute (NCI) has launched an ambitious new nationwide clinical trial to find out if two molecularly targeted drugs that ...

Previous Pulmonary Disease Linked to Increased Lung Cancer Risk in Large Study

Links between a number of common respiratory diseases and an increased risk of developing lung cancer have been found in a large pooled analysis of seven studies involving more than 25,000 individuals. ... Full story

RNA combination therapy for lung cancer offers promise for personalized medicine

Researchers improve therapeutic response in clinically relevant model of lung-tumor growth. ... Full story

Lung cancer diagnosis tool shown to be safe and effective for older patients

A recent study in Manchester has found that a procedure to take tissue samples from lung cancer patients can be used safely in the elderly – allowing doctors to make a more accurate diagnosis and to choose appropriate treatment. ... Full story

Race for 10,000 recruits to detect early signs of lung cancer

With the 10K track race taking place today, the University of Glasgow is embarking on its own, alternative, race. ... Full story

New Treatment Combination Benefited Patients With Lung Cancer

PHILADELPHIA — A combination of the EGFR-targeted anticancer therapeutics afatinib (Gilotrif) and cetuximab (Erbitux) yielded clinical responses in 29 percent of patients who had lung cancer harboring epidermal growth factor receptor (EGFR) mutations that had stopped responding to the EGFR inhibitors erlotinib (Tarceva) and gefitinib (Iressa), according to data from a phase Ib clinical trial published in Cancer Discovery, a journal of the American Association for Cancer Research. ... Full story

Study identifies novel genomic changes in the most common type of lung cancer

TCGA finds mutations in a key cancer-causing pathway, expanding targets for existing drugs ... Full story

Lung cancer study hints at new treatments

By Julia Evangelou Strait - Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors. The new knowledge may expand treatments for patients because drugs targeting some of these genetic changes already are available or are in clinical trials. ... Full story

New Program to Detect Early Lung Cancer in Current and Former Smokers

CT scans lower lung cancer deaths, according to NIH study ... Full story

1 2 3 4 5 6 7 8 9 next total: 83 | displaying: 1 - 10